Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022
BILLERICA, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, provided today a business update and reported preliminary financial results for the fourth quarter and year ended December 31, 2022.
Related news for (CFMS)
- CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. – CFMS
- Conformis, Inc. to Participate in Upcoming Investor Conferences
- Conformis Announces First Procedure Performed Using New Actera™ Hip System